1. Introduction {#s0005}
===============

Development of *Drosophila* thorax has been an excellent model that has aided in our understanding of the morphogenetic processes involved in formation of an organism [@b0005; @b0010]. Several of the processes involved in thoracic development, like epithelial mesenchymal transition, migration, tissue invasion and extracellular matrix remodeling are also processes co-opted by cells that become cancerous and metastatic [@b0015; @b0020]. For this reason an understanding of gene functions, their regulation and processes they control during *Drosophila* thorax development has an added advantage of illuminating the underpinnings of tumor invasion and metastasis.

The adult thorax in drosophila develops from two contra-laterally positioned larval wing imaginal discs that undergo disc eversion and fuse at the midline during pupariation in a process that is referred to as thorax closure [@b0010]. Defects in this closure result in a thoracic cleft phenotype and is observed in mutations of several key genes of the stress activated kinase pathway, called Jun N-Terminal Kinase (JNK) pathway [@b0025]. JNK pathway along with DPP signaling regulates adhesiveness, cytoskeletal dynamics, extracellular matrix remodeling and tissue invasiveness during thorax closure [@b0015; @b0020; @b0030]. Furthermore, it has been demonstrated that the JNK pathway also plays a critical role in tumor invasion and metastasis in *Drosophila* [@b0020; @b0035; @b0040].

In response to upstream signals the JNK pathway phosphorylates AP-1 transcription factors D-Jun and D-Fos. These phosphorylated transcription factors translocate to the nucleus resulting in gene expression of downstream effectors. The core of this pathway is made up of the *Drosophila* JNK (DJNK) encoded by *basket (bsk)*, the *Drosophila* JNKK encoded by *hemipterous (hep)* and the dual specificity phosphatase encoded by the *puckered (puc)* gene [@b0025; @b0045]. Puckered, through its phosphatase activity dephosphorylates the JNK, BSK, to negatively regulate JNK pathway in a feedback loop [@b0025; @b0045]. Thoracic cleft phenotypes have been reported for mutations in *hep*, *dfos*, underscoring the importance of JNK pathway in thoracic development of *Drosophila* [@b0005; @b0010; @b0020; @b0030].

An important downstream effector of the JNK pathway activity in thoracic development is the Matrix Metalloprotease [@b0020; @b0040]. Consequently, mutations in MMPs display the thoracic cleft phenotypes as well as disc eversion defects [@b0020]. It has been shown that MMPs under the regulatory control of JNK pathway remodel a specialized extracellular matrix called Basement Membrane (BM). This BM remodeling is critical for disc eversion and thoracic closure in *Drosophila* [@b0020].

Serine proteases (SP) are catalytically active enzymes that perform a host of functions in animals ranging from food digestion to immunity to development to blood coagulation [@b0050; @b0055]. Serine protease homologs (SPHs) on the other hand, while being similar to serine proteases, have a catalytic triad substitution rendering them catalytically compromised [@b0060; @b0065]. The exact function of these SPH molecules is not very well understood. However, it is suggested that these catalytically dead molecules have acquired new regulatory roles that they may perform in a context dependent manner [@b0070]. Herein, it is demonstrated that a SPH in *Drosophila* encoded by the gene *scarface* [@b0075] plays a role in thoracic development of *Drosophila*. It is shown that *scarface* is expressed in the *Drosophila* wing imaginal disc in regions important for thoracic development and is under regulatory control of the JNK pathway. A possible role for *scarface* during thoracic closure is discussed.

2. Materials and methods {#s0010}
========================

2.1. *Drosophila* stocks and culture {#s0015}
------------------------------------

Standard *Drosophila* culturing techniques were employed. All *Drosophila* cultures were raised on standard corn meal agar medium at 25 °C in vials and bottles unless stated otherwise. Few pellets of Red Star® active dry yeast were added to bottles and vials before culturing. The *scarface* protein trap (*sf^pbss^*) used in this study was a kind gift from Dr. Richard Mann and is described in Bonin and Mann (2004) [@b0075]. *UAS-Dcr-2* (FBti0100276), *Tubulin-Gal80^ts^* (FBti0027798), *hep^R75^* (FBst0006761), *Ptc-Gal4* (FBti0002124), *Ap-Gal4* (FBti0002785), *Pnr-Gal4* (FBti0004011), lines are described in indicated Flybase references and were obtained from the Bloomington *Drosophila* Stock Center. Deficiency lines \[*Df (2R) BSC630*, *Df (2R)BSC696* and *Df (2R)BSC697\]* used in this study delete the *scarface* locus and were obtained from Bloomington Stock Center. *sf^pbss^* protein trap was placed in trans with these deficiencies to test for "scarface phenotype" enhancement. The *UAS-scarface RNAi* line used in this study was obtained from the Vienna *Drosophila* RNAi Center. UAS-dTAK1 is described in Mihaly et al. [@b0080] and was used as described in Srivastava et al. [@b0020].

2.2. Genotype used in various figures {#s0020}
-------------------------------------

[Fig. 1](#f0005){ref-type="fig"}B, D: +/+C, E: *w*; *sf^pbss^*/+F, I: *sf^pbss^*/*Df(2R) BSC630*G, J: *sf^pbss^*/*Df(2R) BSC696*H, K: *sf^pbss^*/*Df(2R) BSC697*[Fig. 2](#f0010){ref-type="fig"}*w*; *sf^pbss^*/+[Fig. 3](#f0015){ref-type="fig"}*y*, *hep^R^*^75^/*Y*; *sf^pbss^*/+[Fig. 4](#f0020){ref-type="fig"}*w*; *Ptc-Gal4, UAS-srcRFP, sf^pbss^/+; UAS-dTAK1*/*Tubulin-Gal80^ts^*[Fig. 5](#f0025){ref-type="fig"}A: Control *w^1118^*, phenotype indistinguishable from *Ap-Gal4/+; UAS-Dcr-2/+*B: *Ap-Gal4*/*+; UAS-Dcr-2/UAS-scarface RNAi*C: *w; +/+; Pnr-Gal4, UAS-Dcr-2*/+D: *w; +/+; Pnr-Gal4, UAS-Dcr-2, UAS-scarface RNAi*/+[Supplementary Fig. 1](#s0070){ref-type="sec"}A: *w; +/+; Ubx-Gal4/UAS-GFP-nls*B--E: *w; sf^pbss^*/+

2.3. Induction of the JNK pathway, fixation of the imaginal discs and subsequent imaging {#s0025}
----------------------------------------------------------------------------------------

*Drosophila* larvae of the genotype *w; Ptc-Gal4, UAS-srcRFP, sf^pbss^/+; UAS-dTAK1*/*Tubulin-Gal80^ts^* were reared at 18 °C and then late second and early third instar larvae were shifted to 29 °C for 30--36 h. The third instar larvae were dissected, fixed and mounted in Vectashield mounting media with DAPI [@b0020]. The mounted imaginal discs were then imaged on a LSM 510 Confocal microscope using sequential acquisition settings.

3. Results and discussion {#s0030}
=========================

3.1. Reagents used in this study and the scarface phenotype {#s0035}
-----------------------------------------------------------

The *scarface* gene encodes a protein that has been classified as a serine protease homolog (SPH) [@b0060; @b0065; @b0075]. SPHs are similar to serine proteases but due to substitution of amino acids in the catalytic triad are rendered inactive [@b0060; @b0065]. Scarface protein contains a signal sequence and has been demonstrated to be a secreted protein [@b0085; @b0090]. To better understand the role of *scarface* in development and to understand its regulation we utilized available reagents for *scarface* ([Fig. 1](#f0005){ref-type="fig"}A). More specifically, in this study a previously published *scarface* protein trap line [@b0075] and a RNA interference (RNAi) line available from the Vienna Drosophila RNAi Center (VDRC) have been used to understand *scarface* function. The *sf^pbss^* protein trap [@b0075] is a semi lethal line where the animals die at pupal stage ([Fig. 1](#f0005){ref-type="fig"}B,C), however some escapers eclose as adults and exhibit a scar made up of necrotic tissue on the posterior side of head ([Fig. 1](#f0005){ref-type="fig"}D, E). This phenotype will be referred as the "*scarface* phenotype" for the rest of this study. In an attempt to generate a more severe *scarface* phenotype, we crossed the *sf^pbss^* protein trap to three deficiencies (*Df (2R) BSC630, Df(2R)* *BSC696 and Df (2R)* *BSC697*) that delete the *scarface* gene. Transheterozygous combinations of the protein trap with these deficiencies resulted in phenotypes that were indistinguishable from the *sf^pbss^* homozygous "*scarface* phenotype" ([Fig. 1](#f0005){ref-type="fig"}F--K). This suggests that the GFP tagged Scarface protein produced from the protein trap retains most of its function and is sufficient to allow animals to reach the pupal stage and in some cases adulthood. We next tested the *scarface* RNAi line obtained from the VDRC for lethality and for generation of the "*scarface* phenotype" when overexpressed ubiquitously using the UAS-Gal4 system [@b0095]. Overexpression of *scarface* RNAi line under the influence of an *Actin-Gal4* driver and in the presence of UAS-DCR2 (for enhancement of the RNAi effect) resulted in pupal lethality and scarring similar to what is shown in [Fig. 1](#f0005){ref-type="fig"}E. This suggests that the RNAi line targets the *scarface* locus and generates the "*scarface* phenotype".

3.2. Scarface is expressed in *Drosophila* wing imaginal disc cells {#s0040}
-------------------------------------------------------------------

It has been previously demonstrated that the *sf^pbss^* protein trap expression mimics the endogenous mRNA pattern during embryonic development (Sorrosal et al., EMBO Reports 2010 in [Fig. 1](#f0005){ref-type="fig"}B--D) [@b0090]. Scarface has also been previously reported to be expressed in the wing imaginal disc cells in the future hinge region [@b0075]. To better understand the distribution of Scarface protein in the developing wing disc and to confirm the previous observations in the hinge, we utilized the *sf^pbss^* protein trap as a readout of endogenous Scarface distribution in the wing imaginal disc. Confocal scans of wing discs from the protein trap demonstrated that the Scarface protein is expressed in the hinge region ([Fig. 2](#f0010){ref-type="fig"}B, arrowheads) as previously described. Additionally, we found expression of Scarface in the peripodial stalk ([Fig. 2](#f0010){ref-type="fig"}B, arrow and [Supplementary Fig. 1](#s0070){ref-type="sec"}) and the peripodial membrane ([Fig. 2](#f0010){ref-type="fig"}E, arrows and [Supplementary Fig. 1](#s0070){ref-type="sec"}) cells. In these peripodial cells, Scarface is excluded from the nucleus and is found predominantly in the cytoplasm ([Fig. 2](#f0010){ref-type="fig"}E, F, dashed circle and [Supplementary Fig. 1](#s0070){ref-type="sec"}). The peripodial stalk is the region of wing disc through which the imaginal disc is attached to the larval epidermis. On the other hand the peripodial epithelium is the region of wing disc that is made up of squamous epithelial cells and is folded over the columnar epithelial wing disc proper [@b0100]. Both the peripodial stalk and the peripodial membrane cells play important roles during thorax development and are regions where the JNK pathway is also active [@b0005].

3.3. JNK pathway is necessary and sufficient for scarface expression in the wing disc {#s0045}
-------------------------------------------------------------------------------------

The finding that Scarface protein is expressed in the peripodial membrane, and the peripodial stalk taken in combination with the known roles of JNK pathway in these tissues, suggested that *scarface* could be regulated by the JNK pathway. To test the necessity of JNK pathway for Scarface expression, we utilized a strong mutation in the D-JNKK encoded by the gene *hemipterous* (*hep^R75^*) [@b0105]. Wing discs derived from larvae hemizygous for *hep^R75^* and also carrying the *scarface* protein trap exhibited diminished Scarface expression as judged by reduced GFP levels in the peripodial stalk and peripodial membrane ([Fig. 3](#f0015){ref-type="fig"}, arrow compared to [Fig. 2](#f0010){ref-type="fig"} B, B', E). This demonstrated that JNK pathway is necessary for Scarface expression.

We next tested to see if JNK pathway was sufficient for the expression of Scarface. To test this we up-regulated this pathway using an upstream component of the JNK pathway called dTAK1 [@b0080] and the UAS-Gal4 system [@b0095]. Because JNK pathway activation results in larval lethality, we controlled the temporal expression of dTAK1 by placing it under the control of *Gal80^ts^* as previously described [@b0020]. Induction of dTAK1 expression was achieved by shifting the larvae of the genotype *Ptc-gal4*, *UAS-RFP*, *sf^pbss^/+; UAS-dTAK1*/*Tubulin-Gal80^ts^* from 18 °C to 29 °C for 30--36 h (please see Section [2](#s0010){ref-type="sec"} for details). Wing discs derived from the temperature shifted larvae showed robust expression of Scarface in the *Ptc-Gal4* domain along the anterior posterior compartment border ([Fig. 4](#f0020){ref-type="fig"}B, arrows). This up-regulation of Scarface in response to JNK pathway activation was also seen in the haltere and leg imaginal discs ([Fig. 4](#f0020){ref-type="fig"}D--F, arrow in E) suggesting that the JNK pathway is sufficient for Scarface expression within the context of these imaginal discs. Similar observations have been made for Scarface expression during embryonic development [@b0085; @b0090].

3.4. scarface knockdown mimics JNK pathway mutant phenotype {#s0050}
-----------------------------------------------------------

Having established that Scarface is expressed in the peripodial stalk and peripodial membrane (JNK pathway is active here) cells under the regulatory control of JNK signaling, we reasoned that Scarface could be one of the effectors of JNK signaling within the context of thoracic development. If this were the case then Scarface knockdown in the developing thorax should result in phenotypes reminiscent of JNK pathway defect (thoracic cleft) [@b0005; @b0010; @b0025]. To knockdown *scarface* in the developing thorax a UAS-*scarface* RNAi line was overexpressed in the domain of *Pannier-Gal4 (Pnr-Gal4)* expression and *Apterous-Gal4 (Ap-Gal4)* expression in combination with UAS-Dcr2 (for RNAi effect enhancement). The *Pnr-Gal4* drives expression of a UAS transgene in the notum area of the wing disc destined to form the dorsal medio-lateral region of the adult thorax as well as thoracic bristles [@b0110]. *Apterous-Gal4*, on the other hand expresses in the dorsal compartment of the wing disc which encompasses the region destined to form the future thorax [@b0110].*scarface* knockdown using the *Ap-Gal4* driver resulted in loss of bristles from the medio-lateral region of the thorax and the thorax displayed a mild thoracic cleft (arrow in [Fig. 5](#f0025){ref-type="fig"}B). *scarface* knockdown using the *Pnr-Gal4* driver resulted in a much stronger thoracic cleft and loss of bristles from the medio-lateral region of the thorax (arrow in [Fig. 5](#f0025){ref-type="fig"}D). The thoracic cleft phenotype is reminiscent of JNK pathway defect and has been recovered for mutations in various components of the JNK pathway [@b0025]. The regulation of *scarface* by the JNK pathway during thoracic development combined with the thoracic cleft phenotype generated when *scarface* is knocked down, suggests that part of the function of JNK during thoracic development is effected through SPH *scarface*.

3.5. Possible function of scarface during *Drosophila* thorax development {#s0055}
-------------------------------------------------------------------------

JNK pathway plays a central role in thorax development and mediates this in at least two ways. First, it regulates the MMPs which in turn regulate the BM degradation, a step critical for the process of disc eversion [@b0020]. Second, JNK signaling along with DPP also regulates the cytoskeletal dynamics and adhesion, properties important for the proper movement of epithelial sheets [@b0030]. A third role of JNK pathway in thoracic development could be the regulation of BM integrity mediated by the SPH *scarface* during thoracic closure. While this needs to be unequivocally demonstrated during thoracic closure, evidence pointing to a similar function of JNK pathway in embryonic dorsal closure mediated by *scarface* already exists. It has been demonstrated by Sorrosal et al. (2010), that *scarface* is under regulatory control of the JNK pathway and is required for proper Laminin localization within the BM during embryonic dorsal closure [@b0090].

While JNK regulation of *scarface* and *its* involvement in thoracic closure has been established in this study, what cellular role does *scarface* play during thoracic development in general and thoracic closure in particular (considering that it is not a catalytically active protein) is open to speculation. It has been suggested that SPHs have evolved into "catalytically dead regulatory molecules" and may exert their regulatory effects by sequestering substrates for serine proteases in a context dependent manner or by stabilizing cellular structures. For example, mutations in a SPH in *Drosophila* encoded by the gene *masquerade* (*mas*) [@b0115] results in muscle attachment defects suggesting that this protein has a stabilizing effect on muscle-cell and matrix interaction. It is possible that, just as scarface stabilizes the integrity of BM by ensuring proper localization of Laminin during embryonic development [@b0090], it may be performing a similar role during thoracic closure also. Future experiments may provide evidence confirming this idea.

During metamorphosis, the larval wing imaginal discs undergo a process of disc eversion where the imaginal discs are everted out of the larval body cavity. A hallmark of this disc eversion process is the degradation of BM mediated by the actions of MMPs under regulatory control of the JNK pathway [@b0020]. However, once the disc eversion has occurred, the wing disc epithelial cells spread and move towards each other by crawling over the larval epidermis [@b0015; @b0030]. For spreading and movement to occur, modulation of the cell-matrix interaction with the underlying larval cells would be required. That this cell-matrix interaction modulation in thoracic closure could be brought about by SPH Scarface is evidenced by the thoracic cleft phenotype generated as a result of *scarface* knockdown. In the absence of this protein, (through RNAi knockdown) the cell-matrix interaction maybe destabilized, resulting in impeded and delayed movement of the two discs towards each other and generation of the thoracic cleft phenotype.

As mentioned earlier, experiments performed to study the function of Scarface in embryonic development have demonstrated that Scarface is indeed required for BM integrity through proper localization of Laminin [@b0090] in the BM [@b0120]. It has also been demonstrated in this study and others that *scarface* is under regulatory control of the JNK pathway [@b0085; @b0090]. Given that BM integrity is compromised during tumor metastasis and because JNK pathway is up-regulated in migrating tumors [@b0020; @b0040; @b0125], it is attractive to suggest that SPH Scarface may play a role in tumor metastasis by regulating BM integrity. Future experiments will help us better understand the role of this SPH in tumor metastasis using a *Drosophila* model [@b0130; @b0135].
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Appendix A. Supplementary data {#s0070}
==============================

Supplementary Fig. 1(A--E) Confocal scans of third instar larval wing discs. (A) Wing disc where Ubx-Gal4 drives UAS-GFP-nls in the peripodial epithelium. (B, C) Scarface is expressed in the peripodial membrane (arrows) as judged by comparison with the disc in A marked for peripodial expression bof Ubx. The nuclei are counterstained blue. (D, E) Scarface is also expressed in the peripodial stalk (arrow). The GFP from Scarface (B, D) and the merge (C, E) is shown.
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![Scarface stocks used in this study and the "*scarface* phenotype". (A) Location of *scarface* stocks used in this study superimposed on the genomic organization of the RB transcript. RNAi refers to the region targeted by the VDRC RNAi stock. PBAc\[PBss\] refers to the GFP protein trap line created by Bonin and Mann (2004) [@b0075] and is referred to as *sf^pbss^*. (B--C) Ventral views of pupae from wild type (*+/+*) or *scarface* genotypes. The *scarface* mutant in C has necrotic scar near the proboscis (arrow). (D and E) Posterior views of head from wild type (*+/+*) adult and *scarface* adult escaper respectively. The necrotic black scar near the proboscis is marked with an arrow. (F--H) Ventral views of Pupae, (I--J) posterior view of head from *sf^pbss^* in transheterozygous combinations with various deficiencies that uncover the *scarface* locus. The scar associated with the "scarface phenotype" is marked with arrows. The transheterozygous combinations are as follows: (F and I) *sf^pbss^*/*Df (2R) BSC630*. (G and J) *sf^pbss^/Df (2R) BSC696* (H and K) *sf^pbss^*/*Df (2R) BSC697*.](gr1){#f0005}

![Scarface is expressed in various regions of the wing disc. (A--F) Confocal scans of third instar larval wing disc. Scarface expression is marked with GFP from *scarface* GFP protein trap (*sf^pbss^*) in B, B', E and nuclei are counterstained with DAPI in A, A', D. The merged channels are presented in C, C' and F. (A--C) Confocal scan through the columnar epithelium of the wing disc. (A'--C') Close-up of the region boxed in A. Expression in the peripodial stalk is marked with an arrow in B and B'. The expression in the hinge region is indicated by arrowheads in B. (D--F) Region boxed in A is presented but of a focal plane from the side of peripodial epithelium. The expression of Scarface in E is marked with arrows and the circle in E and F highlight the nuclear exclusion of Scarface. The peripodial epithelium can be recognized by the presence of large nuclei in D and F.](gr2){#f0010}

![JNK pathway is necessary for Scarface expression. (A--C) Whole mount third larval instar wing disc from a male *sf^pbss^* bearing larva carrying a mutation in the *hemipterous* gene (*hep^r75^*). The region bounded by the box in [Fig. 2](#f0010){ref-type="fig"}A is presented. The disc is oriented with dorsal facing up and ventral facing down. Individual channels are labelled where nuclei are stained with DAPI (blue), Scarface protein trap with GFP. The GFP expression is lost in these wing discs in the region of the peripodial stalk (arrow in B) when compared to [Fig. 2](#f0010){ref-type="fig"}B' suggesting that the JNK pathway is necessary for Scarface expression. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr3){#f0015}

![JNK Pathway is sufficient for Scarface expression. (A--F) Whole mount third instar imaginal discs from third instar larvae capable of activating the JNK pathway in a *Ptc-Gal4* driver pattern along the antero-posterior compartment border. The domain of *Ptc-Gal4* expression is marked by RFP (red channel in A, D) from a UAS-RFP transgene. The Scarface expression is marked with GFP (green channel, arrows in B and E) from *sf^pbss^*. The discs are counterstained with DAPI (blue) to label the nuclei. The merge of individual channels is also shown. Complete genotype of the discs can be found in materials and methods section. A--C are wing discs and D--F are leg and haltere discs labelled as L and H respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr4){#f0020}

![*Scarface* knockdown in wing disc generates a thoracic cleft phenotype. (A--D) Adult thoraxes from control flies (A, C) and from flies where the *scarface* gene has been knocked down (B, D) using the *Ap-Gal4* driver as in B or the *Pnr-Gal4* driver as in D. The knockdown is achieved due to the presence of UAS-*scarface* RNAi and enhanced due to the presence of UAS-DCR2 transgenes. The complete genotype of these flies is provided in [Section 2](#s0070){ref-type="sec"}. Knockdown of *scarface* using the *Ap-Gal4* driver results in mild cleft thorax phenotype with loss of bristles indicated with an arrow in B as compared to control thorax in A. Knockdown of *scarface* using the *Pnr-Gal4* driver results in a more severe cleft thorax (D compared to B) phenotype with loss of bristles and the cleft indicated with arrows. The clefted thorax phenotype is reminiscent of phenotypes caused due to JNK pathway defect.](gr5){#f0025}
